Abbott Laboratories
DE ˙ XTRA ˙ US0028241000
75,22 € ↑1,20 (1,62%)
2026-06-03
AKTIENPREIS
SecurityDE:ABL / Abbott Laboratories
InstitutionPDS Planning, Inc
Latest Disclosed Ownership119,735 shares
Latest Disclosed Value $ 12,293,154
PDS Planning, Inc reports 1.37% decrease in ownership of ABL / Abbott Laboratories

On April 21, 2026 - PDS Planning, Inc filed a 13F-HR form disclosing ownership of 119,735 shares of Abbott Laboratories (DE:ABL) valued at $10,634,863 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 26, 2026 disclosing 121,398 shares of Abbott Laboratories. This represents a change in shares of -1.37% during the quarter. The current value of the position is $9,006,467 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-21 2026-03-31 13F ABBOTT LABORATORIES COM 002824100 119,735 -1,663 -1.37 12,293 -19.17 0.8109
2026-01-26 2025-12-31 13F ABBOTT LABS COM 002824100 121,398 745 0.62 15,210 -5.88 1.0160
2025-10-21 2025-09-30 13F ABBOTT LABS COM 002824100 120,653 -133 -0.11 16,160 -1.63 1.1177
2025-07-24 2025-06-30 13F ABBOTT LABS COM 002824100 120,786 3,464 2.95 16,428 5.56 1.2243
2025-04-24 2025-03-31 13F ABBOTT LABS COM 002824100 117,322 -94 -0.08 15,563 17.18 1.3118
2025-02-10 2024-12-31 13F ABBOTT LABS COM 002824100 117,416 2,055 1.78 13,281 0.97 1.1798
2024-10-30 2024-09-30 13F ABBOTT LABS COM 002824100 115,361 11,334 10.90 13,152 21.68 1.1787
2024-08-08 2024-06-30 13F ABBOTT LABS COM 002824100 104,027 -9,247 -8.16 10,809 -16.04 1.0906
2024-05-01 2024-03-31 13F ABBOTT LABS COM 002824100 113,274 -181 -0.16 12,875 3.09 1.3527
2024-02-01 2023-12-31 13F ABBOTT LABS COM 002824100 113,455 400 0.35 12,488 14.06 1.4224
2023-10-23 2023-09-30 13F ABBOTT LABS COM 002824100 113,055 -5,821 -4.90 10,949 -15.51 1.4166
2023-07-21 2023-06-30 13F ABBOTT LABS COM 002824100 118,876 -10,170 -7.88 12,960 -0.83 1.6571
2023-05-02 2023-03-31 13F ABBOTT LABS COM 002824100 129,046 1,431 1.12 13,067 -6.73 1.8016
2023-01-27 2022-12-31 13F ABBOTT LABS COM 002824100 127,615 42 0.03 14,011 13.50 2.2393
2022-11-02 2022-09-30 13F ABBOTT LABS COM 002824100 127,573 10 0.01 12,344 -10.94 2.2471
2022-07-15 2022-06-30 13F ABBOTT LABS COM 002824100 127,563 51 0.04 13,860 -8.16 2.5085
2022-04-18 2022-03-31 13F ABBOTT LABS COM 002824100 127,512 12,880 11.24 15,092 -6.45 2.6559
2022-01-25 2021-12-31 13F ABBOTT LABS COM 002824100 114,632 24,454 27.12 16,133 51.44 3.0869
2021-10-22 2021-09-30 13F ABBOTT LABS COM 002824100 90,178 333 0.37 10,653 2.28 2.4580
2021-07-26 2021-06-30 13F ABBOTT LABS COM 002824100 89,845 -2,023 -2.20 10,416 -5.39 2.5363
2021-04-20 2021-03-31 13F ABBOTT LABS COM 002824100 91,868 904 0.99 11,009 10.53 3.1957
2021-01-21 2020-12-31 13F ABBOTT LABS COM 002824100 90,964 -1,564 -1.69 9,960 -1.09 3.4187
2020-10-19 2020-09-30 13F ABBOTT LABS COM 002824100 92,528 -7,533 -7.53 10,070 10.07 4.1009
2020-08-11 2020-06-30 13F ABBOTT LABS COM 002824100 100,061 910 0.92 9,149 16.94 4.1459
2020-04-20 2020-03-31 13F ABBOTT LABS COM 002824100 99,151 1,837 1.89 7,824 -7.44 4.9937
2020-02-07 2019-12-31 13F ABBOTT LABS COM 002824100 97,314 -3,779 -3.74 8,453 -0.06 5.3341
2019-10-28 2019-09-30 13F ABBOTT LABS COM 002824100 101,093 950 0.95 8,458 0.43 5.8703
2019-08-14 2019-06-30 13F ABBOTT LABS COM 002824100 100,143 962 0.97 8,422 6.22 6.2638
2019-04-19 2019-03-31 13F ABBOTT LABS COM 002824100 99,181 -900 -0.90 7,929 9.53 6.1621
2019-02-08 2018-12-31 13F ABBOTT LABS COM 002824100 100,081 -836 -0.83 7,239 -2.22 6.2200
2018-11-02 2018-09-30 13F ABBOTT LABS COM 002824100 100,917 44 0.04 7,403 20.33 6.3363
2018-07-26 2018-06-30 13F ABBOTT LABS COM 002824100 100,873 -1,391 -1.36 6,152 0.39 6.0672
2018-05-03 2018-03-31 13F ABBOTT LABS COM 002824100 102,264 38 0.04 6,128 5.04 6.1913
2018-02-13 2017-12-31 13F ABBOTT LABS COM 002824100 102,226 102,226 5,834 5.9079
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.